Joint venture aims to submit an Investigational New Drug application to the FDA by early next year for treatment that targets solid tumors.
Beyond the Ordinary Beyond the Obvious
Beyond the Ordinary Beyond the Obvious
Joint venture aims to submit an Investigational New Drug application to the FDA by early next year for treatment that targets solid tumors.
